Concepedia

Emily C. Brantley

EC

Statistics

Publications

5

Citations

389

H-Index

5

Active since

2008

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Alabama at Birmingham

Actelion (Switzerland)

Emily C. Brantley is an author at The University of Texas MD Anderson Cancer Center specializing in autoimmunity, autoimmune disease, and t cell immunity.

Top concepts

Publications per year

2008–2012

5

Publications

5

Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression

Emily C. Brantley, Burt Nabors, G. Yancey Gillespie et al. · Clinical Cancer Research · 2008 · 185 citations · Full text

Nitric Oxide-Mediated Tumoricidal Activity of Murine Microglial Cells

Emily C. Brantley, Lixia Guo, Chenyu Zhang et al. · Translational Oncology · 2010 · 70 citations · Full text

CD5-Dependent CK2 Activation Pathway Regulates Threshold for T Cell Anergy

Christine M. Sestero, Donald J. McGuire, Patrizia De Sarno et al. · The Journal of Immunology · 2012 · 57 citations · Full text

, , +19

Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer

Sun-Jin Kim, Jang Seong Kim, Seung Wook Kim et al. · Neoplasia · 2011 · 46 citations · Full text

Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist

Sun-Jin Kim, Jang Seong Kim, Seung Wook Kim et al. · Translational Oncology · 2012 · 31 citations · Full text

1–5 of 5